In the Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC

In the Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC

The goal of this activity is for learners to become more aware of new data through expert perspectives on the impacts of those data on clinical practice, delivered through an engaging platform that reaches across a broad demographic of clinicians.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1000383
  • Start Date: 2024-03-27 05:00:00
  • End Date: 2024-03-27 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: Source: Genentech (Any division) - Amount: 56396.0 - Is Kind Support: False
  • Activity Type: Other/Blended Learning
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.